Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Heberto Santos to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Investigational Site Number 840012, Los Angeles, California, 90033
-
Arkansas
- Investigational Site Number 840018, Hot Springs, Arkansas, 71913
-
Missouri
- Investigational Site Number 840015, St Louis, Missouri, 63110
-
Kentucky
- Investigational Site Number 840007, Paducah, Kentucky, 42002
- Investigational Site Number 840013, Lexington, Kentucky, 40536
-
Illinois
- Investigational Site Number 840011, Maywood, Illinois, 60153
-
Germany
- Investigational Site Number 276001, Ulm, 89081
-
France
- Investigational Site Number 250003, Villejuif Cedex, 94805
- Investigational Site Number 250004, Rennes, 35033
Powered by
SC CTSI